##semicolon##
иммунная тромбоцитопения, генотип, ассоциация, риск развития, тяжелое течение.##submission.citations##
Aziz S. P. et al. Association of IL–17A and IL–17F Gene Polymorphisms with Acute Immune Thrombocytopenia in Egyptian Children //Open Journal of Blood Diseases. – 2018. – Т. 8. – №. 03. – С. 49–60.
Elsaid D. S. et al. Interleukin–37, vascular endothelial growth factor A, and transforming growth factor–β1: promising biomarkers in primary immune thrombocytopenia //Expert Review of Hematology. – 2022. – Т. 15. – №. 8. – С. 757–768.
Hassan T. H. M. et al. Role of Interleukin–17 serum level as a prognostic in children with immune thrombocytopenia //NeuroQuantology. – 2022. – Т. 20. – №. 18. – С. 1504.
Ismail A. M. et al. IL–23/Th17 pathway and IL–17A gene polymorphism in Egyptian children with immune thrombocbytopenic purpura //Italian Journal of Pediatrics. – 2021. – Т. 47. – С. 1–8.,
Lin–Lin T. et al. Expression of interleukin–37, vascular endothelial growth factor A, and transforming growth factor–β1 and their correlation with T cells in children with primary immune thrombocytopenia //Chinese Journal of Contemporary Pediatrics. – 2023. – Т. 25. – №. 11.
Razavi A. S. et al. TGF–β signaling and the interaction between platelets and T–cells in tumor microenvironment: Foes or friends? //Cytokine. – 2022. – Т. 150. – С. 155772.
Tan J. H. et al. Scoping review on epigenetic mechanisms in primary immune thrombocytopenia //Genes. – 2023. – Т. 14. – №. 3. – С. 555.